Idiopathic intracranial hypertension: Are there predictors for visual outcome or recurrences?

Creative Commons License

Tata G., Kisabay A., Gokcay F. , Celebisoy N.

Clinical neurology and neurosurgery, vol.183, pp.105378, 2019 (Journal Indexed in SCI Expanded) identifier identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 183
  • Publication Date: 2019
  • Doi Number: 10.1016/j.clineuro.2019.105378
  • Title of Journal : Clinical neurology and neurosurgery
  • Page Numbers: pp.105378


Objective: To find out the predictors of final visual outcome and recurrences in idiopathic intracranial hypertension (IIH). Patients and methods: Medical records of 75 patients with IIH were analyzed retrospectively. Gender, age of disease onset (AODO), body mass index (BMI), lumbar puncture opening pressure (LP-OP), visual acuity (VA) in logMAR, optical disc appearance (ODA), visual field (VF) mean deviation (MD), treatment results and recurrence rates were considered. Results: Mean age at onset age was 32.4 years, BMI was 311 kg/m² and median LP-OP was 380 mm H2O. All patients were treated with acetazolamide with a median dose of 1500 mg. The mean follow-up period was 44.8 months. AODO, BMI, LP-OP were not correlated with any of the examination parameters (VA, ODA, VF) at the first or last visit. The correlation between the VA and VF both at the first and last visit was not very powerful. VA of the last visit was fairly correlated with the VA of the first visit. However, the correlation between the last and first visit VF was very good. A very significant improvement in both VA and VF was recorded after treatment. Recurrences were noted in 23%. Demographic and clinical features of the recurring and non-recurring patients were not significantly different in terms of AODO, BMI, LP-OP, VA, VF or ODA. Conclusions: The patients with IIH respond to treatment with acetazolamide. First visit VF is the main determinant of the final visual outcome. Recurrences cannot be predicted by the demographic or clinical features at presentatio